Track Heart Test Laboratories Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Heart Test Laboratories Inc. Common Stock HSCS · Stock Open Heart Test Laboratories Inc. Common Stock in new tab

2.13 USD
P/E
0.68
EPS
-3.21
P/B
-4.60
ROE
-1851.90
Beta
1.81
Loading chart...
Key Metrics
Earnings dateDec. 21, 2026
P/E0.68
EPS-3.21
Book Value-0.52
Price to Book-4.60
Debt/Equity1741.42
% Insiders19.753%
Growth
Revenue Growth0.11%
Estimates
Forward P/E-1.37
Forward EPS-1.75

DCF valuation

Model fair value for Heart Test Laboratories Inc. Common Stock (HSCS)
Result
Sign in to run the valuation for HSCS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Heart Test Laboratories Inc. Common Stock Logo Heart Test Laboratories Inc. Common Stock Analysis (HSCS)

United States Health Care Official Website Stock

Is Heart Test Laboratories Inc. Common Stock a good investment? Heart Test Laboratories Inc. Common Stock (HSCS) is currently trading at 2.13 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.68. This relatively low multiple may signal that Heart Test Laboratories Inc. Common Stock is undervalued compared to historical market norms.

Earnings Schedule: Heart Test Laboratories Inc. Common Stock is expected to release its next earnings report on Dec. 21, 2026. The market consensus estimate for Forward EPS is -1.75.

Investor FAQ

Does Heart Test Laboratories Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Heart Test Laboratories Inc. Common Stock?

Heart Test Laboratories Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Dec. 21, 2026. The company currently has a trailing EPS of -3.21.

Company Profile

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Exchange Ticker
NMS (United States) HSCS
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
May 17, 2024 1:100
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion